- Title
- Norcantharimide analogues possessing terminal phosphate esters and their anti-cancer activity
- Creator
- Robertson, Mark J.; Gordon, Christopher P.; Gilbert, Jayne; McCluskey, Adam; Sakoff, Jennette A.
- Relation
- Bioorganic & Medicinal Chemistry Vol. 19, Issue 18, p. 5734-5741
- Publisher Link
- http://dx.doi.org/10.1016/j.bmc.2011.01.031
- Publisher
- Elsevier
- Resource Type
- journal article
- Date
- 2011
- Description
- A family of norcantharidin analogues possessing a terminal alcohol (ethanol, propanol, butanol, pentanol, hexanol and cyclohexanol) moiety were treated with either chlorodiethyl, chlorodiphenyl or chloro-bis-trichloroethyl-phosphate to afford highly focused libraries of the corresponding phosphate esters. Subsequent biological screening against a panel of nine human cancer cell lines identified a trend between the ease of phosphate unmasking (phosphate ester hydrolysis) and cell death. The most potent analogues possessed either a diphenyl or a bis-trichloroethyl moiety. The effect of alkyl spacer was also examined with the hexyl analogues typically more potent. 4-Aza-4-(3-{bis(2,2,2-trichloroethyl)phosphate}propyl)-10-oxatricyclo[5.2.1.0]decane-3,5-dione (10b) was the most potent analogue synthesised with an average GI₅₀ of 11 μM across a panel of nine human carcinoma cell lines: colon carcinoma (HT29 and SW480); breast carcinoma (MCF-7); ovarian carcinoma (A2780); lung carcinoma (H460); skin carcinoma (A431); prostate carcinoma (DU145); neuronal carcinoma (BE2-C) and brain carcinoma (SJ-G2). This represents a fivefold improvement in anti-proliferative activity relative to the lead, norcantharidin.
- Subject
- cantharidin; norcantharidin; norcantharimide; cytotoxicity; anti-cancer
- Identifier
- http://hdl.handle.net/1959.13/1063933
- Identifier
- uon:17424
- Identifier
- ISSN:0968-0896
- Language
- eng
- Reviewed
- Hits: 1702
- Visitors: 1692
- Downloads: 0
| Thumbnail | File | Description | Size | Format |
|---|